by admin | Sep 9, 2021 | press-releases
Home PRESS RELEASE CG Oncology Announces Clinical Trial Collaboration with Bristol Myers Squibb to Evaluate Oncolytic Immunotherapy cretostimogene grenadenorepvec in Combination with nivolumab in Metastatic Urothelial Cancer 💻 DESKTOP AUDIO PLAYER...
by admin | Dec 10, 2020 | press-releases
Home PRESS RELEASE CG Oncology Closes $47 Million Series D Financing 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱 MOBILE AUDIO PLAYER =============================== --> Listen to this article now 0:00 0.5x 0.75x Normal...
by admin | Dec 9, 2020 | press-releases
Home PRESS RELEASE CG Oncology Announces First Patient Dosed in Phase 2 Clinical Trial of cretostimogene grenadenorepvec, an Oncolytic Immunotherapy, in Combination with pembrolizumab for Non-Muscle-Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guerin 💻...
by admin | Nov 12, 2020 | press-releases
Home PRESS RELEASE CG Oncology Announces First Patient Dosed in Phase 1b Study of Oncolytic Immunotherapy cretostimogene grenadenorepvec in Combination with nivolumab in Muscle-Invasive Bladder Cancer 💻 DESKTOP AUDIO PLAYER =============================== --> Listen...
by admin | Mar 26, 2020 | press-releases
Home PRESS RELEASE CG Oncology Announces License and Commercialization Agreement with Kissei Pharmaceutical Co., Ltd. for cretostimogene grenadenorepvec in Japan and Other Asian Countries 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this...
by admin | Mar 15, 2019 | press-releases
Home PRESS RELEASE $22 Million Series C Financing 💻 DESKTOP AUDIO PLAYER =============================== --> Listen to this article now 0:00 📱 MOBILE AUDIO PLAYER =============================== --> Listen to this article now 0:00 0.5x 0.75x Normal 1.25x 1.5x 1.75x –...